Comprehensive SRS Regenerex Tissue Attachment

Last updated: November 6, 2024
Sponsor: Zimmer Biomet
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoarthritis

Treatment

Regenerex Tissue Attachment Augments

Clinical Study ID

NCT06615739
CMU2024-12E
  • Ages > 18
  • All Genders

Study Summary

The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient must be 18 years of age or older.

  • Patient must be willing and able to follow directions.

  • The Comprehensive Segmental Revision System was used in cases of:

  1. Non-inflammatory degenerative joint disease including osteoarthritis andavascular necrosis.

  2. Revision where other devices or treatments have failed.

  3. Correction of functional deformity.

  4. Oncology applications including bone loss due to tumor resection.

  • Proximal or total humeral replacement, for: Treatment of acute or chronic fractureswith humeral head (shoulder) involvement, which are unmanageable using othertreatment methods.

  • Distal or total humeral replacement for: Treatment of acute or chronic fractureswith humeral epicondyle (elbow) involvement, which are unmanageable using othertreatment methods.

  • Biomet Comprehensive Segmental Revision System was used in a reverse application inpatients whose shoulder joint has a grossly deficient rotator cuff with severearthropathy and/or previously failed shoulder joint replacement with a grosslydeficient rotator cuff for proximal humeral replacement. The patient must beanatomically and structurally suited to receive the implants and a functionaldeltoid muscle is necessary.

  • The Comprehensive Segmental Revision System was used with bone cement in distalhumeral and total humeral applications.

  • Regenerex Tissue Attachment Augments were used in combination with the ComprehensiveSegmental Revision System

Exclusion

Exclusion Criteria:

  • Absolute contraindications:

  • Infection

  • Sepsis

  • Osteomyelitis

  • Patient is a prisoner

  • Patient is a current alcohol or drug abuser

  • Patient has a psychiatric illness or cognitive deficit that will not allow forproper informed consent

  • Patient is unwilling to consent

  • Relative contraindications:

  • Uncooperative patient or patient with neurologic disorders who is incapable offollowing directions

  • Osteoporosis

  • Metabolic disorders which may impair bone formation

  • Osteomalacia

  • Distant foci of infections which may spread to the implant site

  • Vascular insufficiency, muscular atrophy, or neuromuscular disease

  • The Comprehensive Segmental Revision System was used in a reverse shoulderapplication in patients receiving radiation therapy

  • The Comprehensive Segmental Revision System was used without bone cement in distalhumeral and total humeral applications.

  • Regenerex Tissue Attachment Augments weren't used during the patient's surgery

Study Design

Total Participants: 103
Treatment Group(s): 1
Primary Treatment: Regenerex Tissue Attachment Augments
Phase:
Study Start date:
October 22, 2024
Estimated Completion Date:
December 31, 2026

Study Description

Consecutive subjects implanted with Comprehensive SRS Regenerex Tissue Attachment Augments according to the approved indications, with the longest-term follow-up possible, will be identified and invited to participate in the study.

The primary objective is the assessment of safety by analyzing implant survivorship. This will be established by recording the incidence and frequency of revisions, complications, and adverse events. Relation of the events to the implant and/or procedure should be specified.

The study will include one site. There will be a maximum of 103 patients enrolled in the study.

Connect with a study center

  • Toman Orthopedics and Sports Med

    Boca Raton, Florida 33432
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.